Genomic HLA heterozygosity as a predictive marker for survival in lung cancer patients post immunotherapy
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz446.013
Abstract: Abstract Background We aimed to assess the role of genomic HLA-I/II heterozygosity in the overall survival benefit in patients with unresectable locally advanced, metastatic non-small lung cancer treated by PD1/L1 inhibitors. Methods We collected blood… read more here.
Keywords: hla heterozygosity; heterozygosity; lung cancer; hla ... See more keywords